Inventor
LANGE JOSEPHUS H M
NL27 patents
⚠️ This page may combine multiple inventors who share the name “LANGE JOSEPHUS H M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SOLVAY PHARM BV
15 patentsUS6476060B2Nov 5, 2002
4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
SOLVAY PHARM BV78 citations94
US6974810B2Dec 13, 2005
4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
SOLVAY PHARM BV31 citations91
US7319110B2Jan 15, 2008
1H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity
SOLVAY PHARM BV14 citations83
US7528162B2May 5, 2009
4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
SOLVAY PHARM BV20 citations82
US7524867B2Apr 28, 2009
Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivity
SOLVAY PHARM BV10 citations79
US7109216B2Sep 19, 2006
1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
SOLVAY PHARM BV14 citations79
US7786144B2Aug 31, 2010
Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonists
SOLVAY PHARM BV2 citations61
US7608718B2Oct 27, 2009
4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
SOLVAY PHARM BV2 citations61
US7186741B2Mar 6, 2007
Neurotensin active 2,3,diaryl-pyrazolidine derivatives
SOLVAY PHARM BV6 citations58
US7495108B2Feb 24, 2009
Imidazoline derivatives having CB1-antagonistic activity
SOLVAY PHARM BV0 citations51
US7173044B2Feb 6, 2007
Imidazoline derivatives having CB1-antagonistic activity
SOLVAY PHARM BV0 citations51
US7498348B2Mar 3, 2009
1 H-imidazole derivatives as cannabinoid receptor modulators
SOLVAY PHARM BV0 citations50
US7271189B2Sep 18, 2007
1H-imidazole derivatives as cannabinoid receptor modulators
SOLVAY PHARM BV0 citations50
US7745476B2Jun 29, 2010
1,3,5-trisubstituted 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
SOLVAY PHARM BV0 citations41
US7928134B2Apr 19, 2011
5-aryl-4,5-dihydro-(1H)-pyrazolines as cannabinoid CB1 receptor agonists
SOLVAY PHARM BV0 citations33
LANGE JOSEPHUS H M
5 patentsUS8138174B2Mar 20, 2012
Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition
LANGE JOSEPHUS H M2 citations61
US8063062B2Nov 22, 2011
Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition
LANGE JOSEPHUS H M1 citations47
US8461184B2Jun 11, 2013
Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonists
LANGE JOSEPHUS H M0 citations44
US8937184B2Jan 20, 2015
1H-imidazole derivatives as cannabinoid CB2 receptor modulators
LANGE JOSEPHUS H M0 citations38
US8410135B2Apr 2, 2013
4,5 dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
LANGE JOSEPHUS H M0 citations28